Bernhard Baune
Professor of Psychiatry; Director, Clinic for Mental Health (University Hospital Münster)
Data updated
Research Footprint
Bernhard Baune appears in 5 tracked papers (2023–2026), most studied alongside Ketamine, 5-MeO-DMT and Esketamine, across Depressive Disorders, Treatment-Resistant Depression (TRD) and Suicidality.
Most-cited paper: Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial (64 citations).
Frequent co-authors: Paul Glue, Colleen Loo and Anthony Rodgers.
Background & Research
Bernhard T. Baune is a psychiatrist and academic researcher known for work on mood disorders, cognitive dysfunction, inflammation, and treatment response in depression. He is listed as Professor at the University of Münster and head of the Clinic for Mental Health at the University Hospital Münster. Earlier records also show appointments connected to the University of Melbourne and the University of Adelaide.
Key Impact
A leading psychiatry researcher whose work spans depression, cognition, inflammation, and novel antidepressant treatments, including ketamine studies.
Collaboration Network
10 collaborators· click a node to visit their profile
Full network →